Media coverage
26
Media coverage
Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis Media name/outlet BioSpace Country/Territory United States Date 8/07/25 URL https://www.biospace.com/press-releases/cogent-biosciences-announces-positive-top-line-results-achieving-statistical-significance-across-all-primary-and-key-secondary-endpoints-from-the-summit-trial-of-bezuclastinib-in-patients-with-non-advanced-systemic-mastocytosis Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-Line Results Achieving Statistical Significance Across All Primary And Key Secondary Endpoints From The SUMMIT Trial Of Bezuclastinib In Patients With Non-Advanced Systemic Mastocytosis Media name/outlet MENAFN - Press Releases (English) Country/Territory Jordan Date 7/07/25 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis Media name/outlet StockTitan.net Country/Territory United States Date 7/07/25 URL https://www.stocktitan.net/news/COGT/cogent-biosciences-announces-positive-top-line-results-achieving-wqywmmyim0ot.html Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis Media name/outlet Yahoo! Finance Country/Territory United States Date 7/07/25 URL https://finance.yahoo.com/news/cogent-biosciences-announces-positive-top-110600212.html Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis Media name/outlet Stockwatch Country/Territory Canada Date 7/07/25 URL www.stockwatch.com/News/Item/U-z9490047-U!COGT-20250707/U/COGT Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis Media name/outlet Crwe World Country/Territory United States Date 7/07/25 URL crweworld.com/article/news-provided-by-globenewswire/3676579/cogent-biosciences-announces-positive-top-line-results-achieving-statistical-significance-across-all-primary-and-key-secondary-endpoints-from-the-summit-trial-of-bezuclastinib-in-patients-with-non-advanced-systemic-mastocytosis Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis Media name/outlet PipelineReview Country/Territory Spain Date 7/07/25 URL https://pipelinereview.com/cogent-biosciences-announces-positive-top-line-results-achieving-statistical-significance-across-all-primary-and-key-secondary-endpoints-from-the-summit-trial-of-bezuclastinib-in-patients-with-non-adv/ Persons Nathan Boggs Title Positive Top line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non Advanced Systemic Media name/outlet Market News Publishing Country/Territory United States Date 7/07/25 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis Media name/outlet Health Technology Net Country/Territory United States Date 7/07/25 URL https://healthtechnologynet.com/2025/07/07/cogent-biosciences-announces-positive-top-line-results-achieving-statistical-significance-across-all-primary-and-key-secondary-endpoints-from-the-summit-trial-of-bezuclastinib-in-patients-with-non-adv/ Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints Media name/outlet Kenbridge Victoria Dispatch Country/Territory United States Date 7/07/25 URL https://smb.kenbridgevictoriadispatch.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints Media name/outlet Luverne Journal Country/Territory United States Date 7/07/25 URL https://smb.luvernejournal.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints Media name/outlet MillisMedway - Local Town Pages Country/Territory United States Date 7/07/25 URL https://pr.millismedwaynews.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints Media name/outlet Holliston - Local Town Pages Country/Territory United States Date 7/07/25 URL https://pr.hollistontownnews.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Reports Positive SUMMIT Trial Results for Bezuclastinib in Non-Advanced Systemic Mastocytosis, Prepares for FDA NDA Submission Media name/outlet Nasdaq Country/Territory United States Date 7/07/25 URL https://www.nasdaq.com/articles/cogent-biosciences-reports-positive-summit-trial-results-bezuclastinib-non-advanced Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints... Media name/outlet Hopedale - Local Town Pages Country/Territory United States Date 7/07/25 URL https://pr.hopedaletownnews.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints Media name/outlet TheTidewaterNews.com Country/Territory United States Date 7/07/25 URL https://smb.thetidewaternews.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints Media name/outlet BluegrassLive.com Country/Territory United States Date 7/07/25 URL https://smb.bluegrasslive.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints Media name/outlet Leesville Leader Country/Territory United States Date 7/07/25 URL https://smb.theleesvilleleader.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints... Media name/outlet Clanton Advisor Country/Territory United States Date 7/07/25 URL https://smb.clantonadvertiser.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints... Media name/outlet Demopolis Times Country/Territory United States Date 7/07/25 URL https://smb.demopolistimes.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints Media name/outlet L' Observateur Country/Territory United States Date 7/07/25 URL https://smb.lobservateur.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints Media name/outlet LaGrange Daily News Country/Territory Georgia Date 7/07/25 URL https://smb.lagrangenews.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints Media name/outlet Suffolk News Herald Country/Territory United States Date 7/07/25 URL https://smb.suffolknewsherald.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints Media name/outlet Port Arthur News Country/Territory United States Date 7/07/25 URL https://smb.panews.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints... Media name/outlet Alabama Now Country/Territory United States Date 7/07/25 URL https://smb.alabamanow.com/article/Cogent-Biosciences-Announces-Positive-Top-line-Results-Achieving-Statistical-Significance-Across-All-Primary-and-Key-Secondary-Endpoints-from-the-SUMMIT-Trial-of-Bezuclastinib-in-Patients-with-Non-Advanced-Systemic-Mastocytosis?storyId=686baab6f3489e1d0ab5d163 Persons Nathan Boggs Title Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis Media name/outlet GlobeNewswire Country/Territory United States Date 7/07/25 Persons Nathan Boggs